Pharmiweb.com RSS Feeds 
PharmiWeb Candidate Blog
Features
16 Dec 08
Naseem Javed, widely recognized as global authority on global corporate nomenclature, image and cyber-branding, author of Naming for Power. Naseem is on global name identity projects and lecturing at various conferences on these ICANN issues.
Naseem Javed
15 Dec 08
- Dossier admits UK biotech at breaking point.
- Sector can still flourish – but needs major investment.
- Industry calls for new investment partnership with government.
- Creation of two new investment super funds critical to future success.
Ramsay Smith - Media House
05 Dec 08
Patients are being urged to put people power into action from today by rating the service they receive in hospitals using a new tool on the NHS website.
Editor
03 Dec 08
Paul Hartigan reports from the Financial Times Pharmaceutical Conference: London December 2nd and 3rd 2008
Paul Hartigan
02 Dec 08
Awards for Innovation, Export Achievement and NHS Partnership held at ERBI's Winter Ball at The Imperial War Museum, Duxford on November 29th 2008.
Aviva Grisby - Holdsworth Associates
28 Nov 08
‘More universities should provide courses that offer hands-on experience to better prepare their students.’ This is the response from the Head of Cranfield Health, Professor Joe Lunec, after a report claimed that those leaving universities lacked the required knowledge and skills to progress in the UK’s pharmaceutical industry.
Naomie Stanford-Jones
28 Nov 08
According to recent information from MIND, the leading mental health charity, Patient research released today by the Healthcare Commission has revealed that a shocking 68% of mental health inpatients are still being housed on mixed sex wards, showing no improvement on last year's figures
Editor
26 Nov 08
Our eMarketing team at PharmiWeb Solutions often works with pharma brand teams to find new ways to reach healthcare professionals with news of the latest product or initiative. And sometimes, it can be challenging, with all of the pressures and time constraints that the average primary care practice faces.
Editor
24 Nov 08
We are facing a world where microbes once again have the potential to cause untreatable diseases, due to the resistance to virtually all available drugs. WHO suggests that even if the pharmaceutical industry were to step up the efforts to develop new drugs immediately, some diseases might still not have any effective therapies within the next ten years.
Visiongain
19 Nov 08
It takes courage to invest €300 million in a production site during a time of financial turmoil”,pointed out Karl-Ludwig Kley, Executive Board Chairman of the pharmaceutical company Merck Serono, this week.
Olwen Glynn Owen
17 Nov 08
The global pain market generated total sales of $34bn in 2007 – but what will the figures be in the next 5 and 10 years? This report tells you.
The pain market has marked strengths and advantages, but is also limited by problems and concerns.
Suvitha Damodaran - Visiongain - Ltd
14 Nov 08
White paper from CERAM highlights novel techniques to expose fake medicines and unlicensed manufacturing processes
Mandy Rymill - CERAM
14 Nov 08
The UK’s success as a global centre of biomedical excellence is under threat in the long-term. A new report by the Association of the British Pharmaceutical Industry (ABPI) has highlighted serious concerns about the supply of skills that support the research and development of new medicines.
Editor
14 Nov 08
The global addiction market is significantly undervalued. The world’s population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents?
Suvitha Damodaran - Visiongain Ltd
10 Nov 08
The gastrointestinal (GI) disorders market has been one of the largest and most profitable therapeutic areas in the world pharmaceutical industry. With a reported $49.9bn in revenues in 2007, the GI disorders market competes consistently with cardiovascular diseases and oncology for the top 3 therapeutic areas in terms of market value.
Suvitha Damodaran - Visiongain
04 Nov 08
There is great potential for the women’s reproductive disorders therapeutics market – can you maximise your company’s potential in this growing market?
Andres Arias - Visiongain
04 Nov 08
NHS Direct estimate that one in five UK women over forty years of age suffer from stress incontinence and, whilst it is often caused by childbirth or menopause, it can affect any women at any age.
Sian Rees
03 Nov 08
Recent reports state that between four and five percent of the population suffer from Dyslexia. It is estimated that there are about 375,000 pupils in the UK with dyslexia and a total of some two million people who are severely affected. Yet it still can be difficult for parents to find the right help for their children.
Editor
31 Oct 08
Scientists have discovered the two key processes that allow cancer cells to change the way they move in order to spread through the body, reports leading scientific journal 'Cell'
Editor
31 Oct 08
Procter & Gamble Pharmaceuticals (P&GP) acknowledges the publication of the new Technology Appraisal Guidance (TAG 160, for the primary prevention, and 161 for the secondary prevention, of osteoporotic fragility fractures in post-menopausal women) issued by NICE.
Sebastian Stokes -Red Door Communications
31 Oct 08
Chemistry researchers at The University of Warwick and the John Innes Centre, have found a novel signalling molecule that could be a key that will open up hundreds of new antibiotics unlocking them from the DNA of the Streptomyces family of bacteria.
Editor
30 Oct 08
Following a strong performance in the third quarter, the Bayer Group confirms its targets for 2008. “Despite the difficult environment we expect in the fourth quarter, we are confirming our guidance for 2008 as a whole,”
Editor
30 Oct 08
The global financial crisis could seriously delay the discovery and production of many new life-saving medicines, warns a major international conference.
Editor
29 Oct 08
The following is taken from the ABPI's Press Release dated 29th October 2008
ABPI press office
24 Oct 08
Global survey shows how perceptions of healthcare professionals and patients influence treatment of bipolar disorder
Olwen Glynn Owen - Pharmiweb Field Reporter
24 Oct 08
NHS staff (in England) are making excellent progress against two key priority areas - to reduce waiting times to 18 weeks and cut Clostridium difficile (C. difficile) infections - statistics released today show.
Editor
23 Oct 08
This brand new report examines the commercial prospects for in vitro diagnostics (IVD) in the global healthcare market. Importantly, this report also covers theranostics, a fusion of drug therapy and diagnostics to optimise efficacy and safety, as well as streamlining drug development.
Editor
21 Oct 08
Boehringer Ingelheim and the search for new targeted cancer treatments
Kelly Smith - OgilvyHealthPR
20 Oct 08
The ever-evolving healthcare industry has very few constants, and the pharmaceutical sales industry is just another piece of the puzzle that is in the middle of a major transformation. For multinationals, eager to sell their drugs in different countries, juggling between scores of different languages and different laws has always proved to be a major dampener.
A. Nair
19 Oct 08
This week, organizations around the globe are working to create awareness and educate people about the signs, symptoms, treatment and prevention of one of the leading causes of death and disability––stroke. Wednesday, 29 October officially marks World Stroke Day.
Alex Young
